Diabetes Research and Clinical Practice · Oct 21, 2026
Prediabetes phenotypes and the development and regression of metabolic dysfunction-associated fatty liver disease: A prospective cohort study
By He M, Liu Y, Guo Y et al.
AIMS: Prediabetes is associated with metabolic dysfunction-associated fatty liver disease (MAFLD), but few studies have assessed the impact of prediabetes phenotypes on the development and regression of MAFLD. We aimed to examine these associations. METHODS: This prospective cohort study included 4768 participants with prediabetes and normal glucose tolerance (NGT) who were followed-up for approximately 3 years. Prediabetes was classified as an isolated glucometabolic defect (isolated impaired fasting glucose [IFG], impaired glucose tolerance [IGT], or impaired hemoglobin A1c [IA1c]), two glucometabolic defects (IFG + IGT, IFG + IA1c, or IGT + IA1c), and all three glucometabolic defects (IFG + IGT + IA1c). Their associations with the development and regression of MAFLD were assessed using multivariable logistic regression. RESULTS: Among 4768 participants, 2687 were with MAFLD and 2081 were without. Compared with NGT, the multivariable-adjusted odds of incident MAFLD were increased by 45% (95% CI 1.09-1.93) and 92% (95% CI 1.13-3.26) among participants with two and three glucometabolic defects, respectively. In contrast, the odds of MAFLD regression were decreased by 38% (95% CI 0.46-0.82) and 62% (95% CI 0.23-0.61), correspondingly. CONCLUSION: Greater numbers of glucometabolic defects were associated with higher odds of incident MAFLD but lower odds of MAFLD regression in prediabetes.
doi.org/10.1016/j.diabres.2026.113622PubMed 42906758Populations